Shepherd Financial Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Shepherd Financial Partners’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,690	Closed	-$1.04M	–	113
2017 Q3	$1.04M	Sell	15,690 -8	-0.1%	-$505	0.24%	53
2017 Q2	$979K	Buy	15,698 +143	+0.9%	+$8.58K	0.24%	58
2017 Q1	$903K	Buy	15,555 +388	+3%	+$22.7K	0.23%	60
2016 Q4	$868K	Buy	+15,167	New	+$873K	0.25%	60

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Shepherd Financial Partners's PJP Position: Q4 2017 in Review

Shepherd Financial Partners sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2017, closing a stake of 15,690 shares — an estimated $1.04M sold.

Shepherd Financial Partners first reported a position in PJP in Q4 2016 and held it in 4 quarters. The position peaked at $1.04M in Q3 2017. 92 funds tracked by Wall St. Rank hold PJP as of Q4 2017.

Shepherd Financial Partners reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
Shepherd Financial Partners sold 15,690 Invesco Pharmaceuticals ETF shares in Q4 2017, an estimated $1.04M.
Shepherd Financial Partners first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 4 quarters.
Shepherd Financial Partners's Invesco Pharmaceuticals ETF position peaked at $1.04M in Q3 2017.
92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2017.

Based on Shepherd Financial Partners's 13F filing for Q4 2017, filed 14 Feb 2018.